[Gynecologic monitoring of tamoxifen treatment of breast cancer].
D000230:Adenocarcinoma / Q000139:chemically induced / Q000175:diagnosis; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D016889:Endometrial Neoplasms / Q000139:chemically induced / Q000175:diagnosis; D005260:Female; D005831:Genital Diseases, Female / Q000139:chemically induced* / Q000175:diagnosis / Q000000981:diagnostic imaging; D005836:Genitalia, Female / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D008991:Monitoring, Physiologic; D010049:Ovarian Diseases / Q000139:chemically induced / Q000175:diagnosis; D013629:Tamoxifen / Q000009:adverse effects*; D014463:Ultrasonography; D014591:Uterine Diseases / Q000139:chemically induced / Q000175:diagnosis; D014623:Vaginal Diseases / Q000139:chemically induced / Q000175:diagnosis
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen
Surveillance gynécologique des traitements du cancer du sein par le tamoxifène.